by European Public Health Alliance | Nov 14, 2020 | Opinion
Guest article | Lydie Meheus PhD, Managing Director, Belgian Anticancer FundCancer patients want to have access to the best available treatment and they want it fast, as in many cases they expect it to be lifesaving.Unfortunately, the current system to bring a new...
by European Public Health Alliance | Nov 14, 2020 | Consultation Responses, Opinion
We have come a long way in a short period of time since the adoption of the groundbreaking June 2016 Council Conclusions on pharmaceuticals. The conclusions were a milestone for the access to medicines debate as they signaled the political acknowledgment of the series...
by European Public Health Alliance | Nov 10, 2020 | Position & Policy Papers
What do we know when a new medicine is approved? What are the regulatory requirements for new medicines? What happens once a new drug is on the market?Following the first of the EPHA #A2MDialogues, our panelists Andrea Cipriani, Lydie Meheus, Huseyin Naci and Beate...
